|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
41.050 -1.200 (-2.840%) | 2022/12 - Final RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,162,719 | 892,374 | 537,551 | 509,373 |
| Net Cash from / (used in) Investing Activities | -- | (2,521,608) | (2,231,312) | (609,370) | (376,004) |
| Net Cash from / (used in) Financing Activities | -- | (163,093) | 9,339,458 | 1,352,811 | 45,972 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (1,521,982) | 8,000,520 | 1,280,992 | 179,341 |
| Cash & Cash Equivalents at beginning of period | -- | 9,959,963 | 2,006,926 | 698,186 | 521,632 |
| Effect of Foreign Exchange Rate Changes | -- | (59,564) | (47,483) | 27,748 | (2,787) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 8,378,417 | 9,959,963 | 2,006,926 | 698,186 |
| Remarks: | Real time quote last updated: 21/09/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,388,337 |
| %Change | 16.471% |
| EPS / (LPS) | RMB 1.610 |
| NBV Per Share (¥) | RMB 23.657 |